Topical application of HIV DNA vaccine with cytokine-expression plasmids induces strong antigen-specific immune responses

By Liu L.-J.   Watabe S.   Yang J.   Hamajima K.   Ishii N.   Hagiwara E.   Onari K.   Xin K.-Q.   Okuda K.  

Vaccine, Vol. 20, Iss. 1, 2001-10 ,pp. : 42-48

Elsevier

Access to resources Recommend Favorite

Recombinant DNA encoding mumps virus antigen; used in recombinant vaccine construction

By Sk Beecham  

Vaccine, Vol. 13, Iss. 7, 1995-01 ,pp. : 695-695

Elsevier

Access to resources Recommend Favorite

Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design

By Herrera O.B.   Brett S.   Lechler R.I.  

Vaccine, Vol. 21, Iss. 3, 2002-12 ,pp. : 231-242

Elsevier

Access to resources Recommend Favorite

Co-expression of granulocyte-macrophage colony-stimulating factor with antigen enhances humoral and tumor immunity after DNA vaccination

By Sun X.   Hodge L.M.   Jones H.P.   Tabor L.   Simecka J.W.  

Vaccine, Vol. 20, Iss. 9, 2002-01 ,pp. : 1466-1474

Elsevier

Access to resources Recommend Favorite

Mucosal binding compositions for generating mucosal immune response; Chlamydia, HIV virus, hepatitis B virus or enterotoxigenic Escherichia coli antigen and cholera toxin binding subunit fusion protein expression, for use as a recombinant vaccine

By Lebens M.   Holmgren J.  

Vaccine, Vol. 14, Iss. 13, 1996-09 ,pp. : 1299-1299

Elsevier

Access to resources Recommend Favorite